NIPT
Non-Invasive Prenatal Testing (NIPT)
At Novo Genomics, we provide cutting-edge Non-Invasive Prenatal Testing (NIPT) to empower expectant parents with accurate, safe, and early insights into their baby’s health. Leveraging advanced genomic technology and local expertise in Saudi Arabia, our NIPT delivers reliable results for informed decision-making during pregnancy.
Our Approach
Our NIPT analyzes cell-free fetal DNA from a maternal blood sample to screen for chromosomal abnormalities, including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). Designed for accuracy and safety, our process uses next-generation sequencing to provide results as early as 10 weeks of pregnancy.
- Non-invasive maternal blood sample collection.
- Advanced next-generation sequencing for precise analysis.
- Expert interpretation by certified genetic specialists.
- Fast results delivered within 5-7 working days.
- Rigorous quality assurance for reliable outcomes.
- Comprehensive reports tailored for healthcare providers.
Included and Excluded Services
- NIPT screening for common trisomies (21, 18, 13).
- Optional screening for sex chromosome abnormalities.
- Post-test genetic counseling session.
- Secure online portal for result access.
- Support from our expert laboratory team.
- Invasive diagnostic tests (e.g., amniocentesis, CVS).
- Extended genetic panels beyond standard NIPT.
- Non-medical or personal consultations.
- Expedited processing outside standard timelines.
Top Highlights
Novo Genomics’ NIPT stands out for its precision, safety, and accessibility. Tailored for families in Saudi Arabia, our test combines global genomic expertise with local care, ensuring trusted results that support confident pregnancy journeys.
- 99%+ accuracy for detecting common chromosomal conditions.
- Safe, non-invasive testing from 10 weeks gestation.
- Results delivered in 7 working days.
- Optional fetal sex determination included.
- Trusted by healthcare providers across the region.